Victory Capital Management’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,342
| Closed | -$10.7K | – | 2524 |
|
|
2025
Q1 | $10.7K | Sell |
15,342
-97
| -0.6% | -$68 | ﹤0.01% | 2451 |
|
|
2024
Q4 | $12.8K | Buy |
15,439
+133
| +0.9% | +$111 | ﹤0.01% | 2465 |
|
|
2024
Q3 | $14.5K | Sell |
15,306
-173
| -1% | -$164 | ﹤0.01% | 2461 |
|
|
2024
Q2 | $11.2K | Buy |
15,479
+465
| +3% | +$337 | ﹤0.01% | 2462 |
|
|
2024
Q1 | $11.6K | Buy |
15,014
+1,879
| +14% | +$1.45K | ﹤0.01% | 2463 |
|
|
2023
Q4 | $18.4K | Buy |
13,135
+2,568
| +24% | +$3.6K | ﹤0.01% | 2511 |
|
|
2023
Q3 | $25.1K | Buy |
10,567
+336
| +3% | +$800 | ﹤0.01% | 2435 |
|
|
2023
Q2 | $49K | Sell |
10,231
-238
| -2% | -$1.14K | ﹤0.01% | 2388 |
|
|
2023
Q1 | $59.4K | Sell |
10,469
-92
| -0.9% | -$522 | ﹤0.01% | 2427 |
|
|
2022
Q4 | $59.1K | Sell |
10,561
-4
| -0% | -$22 | ﹤0.01% | 2430 |
|
|
2022
Q3 | $68K | Buy |
+10,565
| New | +$68K | ﹤0.01% | 2527 |
|
|
2021
Q3 | – | Sell |
-15,797
| Closed | -$377K | – | 2816 |
|
|
2021
Q2 | $377K | Sell |
15,797
-6,944
| -31% | -$166K | ﹤0.01% | 2333 |
|
|
2021
Q1 | $468K | Sell |
22,741
-38,765
| -63% | -$798K | ﹤0.01% | 2235 |
|
|
2020
Q4 | $1.51M | Buy |
61,506
+16,906
| +38% | +$414K | ﹤0.01% | 1611 |
|
|
2020
Q3 | $1.26M | Buy |
+44,600
| New | +$1.26M | ﹤0.01% | 1606 |
|
|
2020
Q2 | – | Sell |
-9,844
| Closed | -$36K | – | 2946 |
|
|
2020
Q1 | $36K | Buy |
+9,844
| New | +$36K | ﹤0.01% | 2890 |
|
|
2019
Q4 | – | Sell |
-6,832
| Closed | -$27K | – | 2998 |
|
|
2019
Q3 | $27K | Buy |
+6,832
| New | +$27K | ﹤0.01% | 2942 |
|